SYROS PHARMACEUTICALS (SYRS) Net Income by Year
SYROS PHARMACEUTICALS INC reported a net loss of $164.6M in fiscal year 2023. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2023 through Q3 FY2024, the same line adds up to a $97.8M net loss. The table below carries 10 fiscal years, from 2014 to 2023, and the quarters SYROS PHARMACEUTICALS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SYRS Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.
SYRS Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More SYROS PHARMACEUTICALS INC financials
Frequently Asked Questions
What was SYROS PHARMACEUTICALS INC's net income in fiscal year 2023?
SYROS PHARMACEUTICALS INC reported a net loss of $164.6M in fiscal year 2023.
How fast is SYROS PHARMACEUTICALS INC's net income growing?
SYROS PHARMACEUTICALS INC (SYRS) reported a $94.7M net loss in fiscal year 2022 and a $164.6M net loss in fiscal year 2023. A growth rate is not meaningful here, because the earlier figure was zero or negative.
What is SYROS PHARMACEUTICALS INC's net income over the last twelve months?
SYROS PHARMACEUTICALS INC (SYRS) reported a $97.8M net loss over the trailing 12 months, Q4 FY2023 through Q3 FY2024, summed from the four most recent quarterly filings.
How has SYROS PHARMACEUTICALS INC's net income changed over the years?
Across the 10 fiscal years this page covers, SYROS PHARMACEUTICALS INC (SYRS) net income went from -$13.4M in fiscal year 2014 to -$164.6M in fiscal year 2023.
What was SYROS PHARMACEUTICALS INC's net income in the most recent quarter?
SYROS PHARMACEUTICALS INC (SYRS) reported -$6.4M in net income in Q3 2024. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what SYROS PHARMACEUTICALS INC (SYRS) reported on that line in every period on record.